Published • loading... • Updated
Kanglong Huacheng Plans $5 Billion Expansion of Production Capacity: What’s the Confidence?
Summary by chinamoneynetwork.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Kanglong Huacheng Plans $5 Billion Expansion of Production Capacity: What’s the Confidence?
Kanglong Huacheng, a leading domestic CRO company, revealed two major expansion plans with a total investment of $5 billion. The company intends to invest $2 billion to establish a new drug commercial production and CDMO R&D production service base in Qiantang District, Hangzhou, expected to be operational by 2029. Additionally, Kanglong Huacheng plans to set up a wholly-owned subsidiary, Kanglong Huacheng (Hangzhou) New Drug Production Co., Ltd…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
